Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives
Authors
Keywords
Multidrug resistance, P-glycoprotein, Protoflavones, Pro-oxidative activity, Reactive oxygen species, Collateral sensitivity
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 76, Issue 3, Pages 555-565
Publisher
Springer Nature
Online
2015-07-21
DOI
10.1007/s00280-015-2821-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux
- (2014) Doriane Lorendeau et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance
- (2014) Gergely Szakács et al. CHEMICAL REVIEWS
- Collateral sensitivity: ABCG2-overexpressing cells are more vulnerable to oxidative stress
- (2014) Damian Krzyżanowski et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inhibition of Glutathione Peroxidase Mediates the Collateral Sensitivity of Multidrug-resistant Cells to Tiopronin
- (2014) Matthew D. Hall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Manganese Superoxide Dismutase Regulates a Redox Cycle Within the Cell Cycle
- (2013) Ehab H. Sarsour et al. ANTIOXIDANTS & REDOX SIGNALING
- Total Synthetic Protoapigenone WYC02 Inhibits Cervical Cancer Cell Proliferation and Tumour Growth through PIK3 Signalling Pathway
- (2013) Yun-Ju Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing
- (2013) Ana Podolski-Renić et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling
- (2013) Yun-Ju Chen et al. GYNECOLOGIC ONCOLOGY
- The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway
- (2013) Yun-Ju Chen et al. LIFE SCIENCES
- Protoflavones: a class of unusual flavonoids as promising novel anticancer agents
- (2013) A. Hunyadi et al. PHYTOCHEMISTRY REVIEWS
- RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1α and inhibition phosphorylation of AKT and mTOR
- (2012) Ziwei Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link-Generating Agents In Vitro and In Vivo
- (2012) H.-C. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines
- (2011) Ana Podolski-Renić et al. BIOMEDICINE & PHARMACOTHERAPY
- A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species
- (2011) Huei-Mei Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- ABC transporters affect the detection of intracellular oxidants by fluorescent probes
- (2011) Jiřina Procházková et al. FREE RADICAL RESEARCH
- Direct Semi-Synthesis of the Anticancer Lead-Drug Protoapigenone from Apigenin, and Synthesis of Further New Cytotoxic Protoflavone Derivatives
- (2011) Attila Hunyadi et al. PLoS One
- Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π
- (2010) Wen-Ying Chen et al. INVESTIGATIONAL NEW DRUGS
- Antitumor Agents. 280. Multidrug Resistance-Selective Desmosdumotin B Analogues
- (2010) Kyoko Nakagawa-Goto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fern Plant–Derived Protoapigenone Leads to DNA Damage, Apoptosis, and G2/M Arrest in Lung Cancer Cell Line H1299
- (2009) Chien-Chih Chiu et al. DNA AND CELL BIOLOGY
- Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
- (2009) Lavinia Nardinocchi et al. Molecular Cancer
- Is resistance useless? Multidrug resistance and collateral sensitivity
- (2009) Matthew D. Hall et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo
- (2008) Hsueh-Ling Chang et al. CANCER LETTERS
- Manganese Superoxide Dismutase Modulates Hypoxia-Inducible Factor-1 Induction via Superoxide
- (2008) S. Kaewpila et al. CANCER RESEARCH
- Protoapigenone, a Novel Flavonoid, Induces Apoptosis in Human Prostate Cancer Cells through Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase 1/2
- (2008) H.-L. Chang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started